Table 1.
Different lots of AAV8 and AAV2 viral vectors used in this study.
| AAV | Lot number | CMV target (vg/ml) | eGFP target (vg/ml) | Production platform | Manufacturer |
|---|---|---|---|---|---|
| AAV8-CMV-eGFP | A-HEK-1 | 6.53 E+12 | 6.69 E+13 | HEK293 cells | University of Iowa |
| A-HEK-2 | 4.61 E+12 | 4.57 E+12 | HEK293 cells | University of Iowa | |
| A-HEK-3 | 5.88 E+12 | 5.97 E+12 | HEK293 cells | University of Iowa | |
| A-Sf9-1 | 4.45 E+13 | 5.09 E+13 | Sf9 cells | University of Iowa | |
| A-Sf9-2 | 1.15 E+14 | 1.31 E+14 | Sf9 cells | University of Iowa | |
| B-HEK-1 | 5.24 E+12 | 5.83 E+12 | HEK293 cells | Virovek | |
| B-Sf9-1 | 2.50 E+13 | 2.84 E+13 | Sf9 cells | Virovek | |
| C-HEK-1 | 3.63 E+13 | 3.69 E+13 | HEK293 cells | Vigene | |
| AAV2-CMV-eGFP | B-Sf9-1 | 2.47 E+13 | 2.74E+13 | Sf9 cells | Virovek |
| B-Sf9-2 | 1.96 E+13 | 2.06E+13 | Sf9 cells | Virovek | |
| C-HEK-1 | 9.59 E+12 | 1.23E+13 | HEK293 cells | Vigene | |
| C-HEK-2 | 9.73 E+12 | 1.12E+13 | HEK293 cells | Vigene |